Kathleen Tregoning

Kathleen Tregoning

DirectoratSpero Therapeutics· In proxies 2023–2025

Kathleen Tregoning sits on 1 public board.

Boards1

  • Spero TherapeuticsDirector · 2 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Spero TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -25%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?